<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
x

Combination Screening of I/O and Targeted Agents In Vitro

To advance preclinical immuno-oncology drug discovery, CrownBio has developed a syngeneic model screening platform for evaluating the in vivo efficacy of immuno-oncology agents (MuScreen™, Poster A64).